• Home
  • About Us
    • AdAlta at a glance
    • Board
    • Management Team
  • Cancer Cell Therapies
    • “East to West” strategy
    • “East to West” product pipeline
  • I-Body Therapeutics
    • i-bodies
    • AD-214: A new approach to fibrotic disease
    • Fibrosis
  • Investors
    • Annual and Financial Reports
    • Presentations
    • Analyst Reports
    • ASX Announcements
    • News & Media
    • Corporate Governance
  • Contact Us

Initial Director’s Interest Notice (3)

Initial Director's Interest Notice (3)

Archives

2018

..

2017

..

2016

..

2015

..

2014

..

2013

..

2012

..

2011

..
© 2025 AdAlta Limited Disclaimer | Privacy Policy
© 2016 AdAlta Limited